All manufacturing activities at Indian Pharma company Marion Biotech Pvt Ltd have been stopped following allegations by Uzbekistan that at least 18 children died in the country after consuming the medicine.
The manufacturing activities have been stopped after the inspection by the Central Drugs Standard Control Organisation (CDSCO). A joint inspection of the manufacturer’s Noida facility was carried out by the teams of the Uttar Pradesh Drug Control Department and CDSCO.
“Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing”, said Union Health Minister Mansukh Mandaviya in a tweet on Friday.
However, the further investigation is in progress by the government agencies. The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.
The All India Institute of Medical Sciences on Wednesday flagged concern over a spurt in…
The Federation of Resident Doctors’ Association (FORDA) strongly condemns the National Board of Examinations’ arbitrary…
Dismissing the recent claims of linking eggs to cancer risk, the Food Safety and Standards…
Across India’s food landscape, quiet substitutions have begun shaping what reaches the plate. The cubes…
The Association of Healthcare Providers (India) (AHPI), the apex body representing nearly 20,000 hospitals across…
In a major advancement for the surgical landscape in India, Apollo Spectra Hospital has unveiled…